Stability of chicken IgY antibodies freeze-dried in the presence of lactose, sucrose and threalose

Journal of Poultry Science

Volumn 44, Issue 1, 2007, Pages 58-62

  Nilsson, Elin ^a   Larsson, Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ELISA; Freeze drying; IgY; Lactose; Sucrose; Threalose

Indexed keywords

AVES;

EID: 33847318645     PISSN: 13467395     EISSN: 13490486     Source Type: Journal    
DOI: 10.2141/jpsa.44.58     Document Type: Article

References (29)

1. Allison SD, Chang B, Randolph TW and Carpenter JF. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Archives of Biochemistry and Biophysics, 365 : 289-298. 1999.
2. Arakawa T, Prestrelski SJ, Kenney WC and Carpenter JF. Factors affecting short-term and long-term stabilities of proteins. Advanced Drug Delivery Reviews, 46 : 307-326. 2001.
3. Baertschi SW. Drugs and the Pharmaceutical Sciences #153 : Pharmaceutical Stress Testing : Predicting Drug Degradation. Taylor & Francis, London. 2005.
4. Carlander D, Stålberg J and Larsson A. Chicken antibodies. A clinical chemistry perspective. Upsala Journal of Medical Sciences, 104 : 179-190. 1999.
5. Carlander D, Olesen H, Kollberg H, Johannesson M, Wejåker PE and Larsson A. Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis : A phase I feasibility study. Pediatric Pulmonology, 35 : 433-440. 2003.
6. Chang BS and Fischer NL. Development of an efficient single-step freeze-drying cycle for protein formulations. Pharmaceutical Research, 12 : 831-837. 1995.
7. Cleland JL, Powell MF and Shire SJ. The development of stable protein formulations : a close look at protein aggregation, deamidation, and oxidation. Critical Reviews in Therapeutic Drug Carrier Systems, 10 : 307-377. 1993.
8. Cleland JL, Lam X, Kendrick B, Yang J, Yang TH, Overcashier D, Brooks D, Hsu C and Carpenter JF. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. Journal of Pharmaceutical Sciences, 90 : 310-321. 2001.
9. Draber P, Draberova E and Novakova M. Stability of monoclonal IgM antibodies freeze-dried in the presence of trehalose. Journal of Immunological Methods, 181 : 37-43. 1995.
10. Duddu SP, and Dal Monte PR. Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody. Pharmaceutical Research, 14 : 591-595. 1997.
11. Garzon-Rodriguez W, Koval RL, Chongprasert S, Krishnan S, Randolph TW, Warne NW and Carpenter JF. Optimizing storage stability of lyophilized recombinant human interleukin-11 with disaccharide/hydroxyethyl starch mixtures. Journal of Pharmaceutical Sciences, 93 : 684-696. 2004.
12. Hatta H, Tsuda K, Ozeki M, Kim M, Yamamoto T, Otake S, Hirasawa M, Katz J, Childers NK and Michalek SM. Passive immunization against dental plaque formation in humans : effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Research, 31 : 268-274. 1997.
13. Hsu CC, Nguyen HM, Yeung DA, Brooks DA, Koe GS, Bewley TA and Pearlman R. Surface denaturation at solid-void interface-a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures. Pharmaceutical Research, 12 : 69-77. 1995.
14. Kobayashi C, Yokoyama H, Nguyen SV, Kodama Y, Kimata T and Izeki M. Effect of egg yolk antibody on experimental Cryptosporidium parvum infection in seid mice. Vaccine, 23 : 232-235. 2004.
15. Larsson A, Karlsson-Parra A and Sjöquist J. Use of chicken antibodies in enzyme immunoassays to avoid interference by rheumatoid factors. Clinical Chemistry, 37 : 411-414. 1991.
16. Larsson A and Mellstedt H. Chicken antibodies : a tool to avoid interference by human anti-mouse antibodies in ELISA after in vivo treatment with murine monoclonal antibodies. Hybridoma, 11 : 33-39. 1992.
17. Manning MC, Patel K and Borchardt RT. Stability of protein pharmaceuticals. Pharmaceutical Research, 6 : 903-918. 1989.
18. Millqvist-Fureby A, Malmsten M and Bergenstahl B. Surface characterisation of freeze-dried protein/carbohydrate mixtures. International Journal of Pharmaceutics, 191 : 103-114. 1999.
19. Nielsen K. Stability of freeze dried horseradish peroxidase conjugated monoclonal antibodies used in diagnostic serology. Journal of Immunoassay, 16 : 183-197. 1995.
20. Omidfar K, Rasaee MJ, Zaraee AB, Amir MP and Rahbarizadeh F. Stabilization of penicillinase-hapten conjugate for enzyme immunoassay. Journal of Immunoassay and Immunochemistry, 23 : 385-398. 2002.
21. Prestrelski SJ, Pikal KA and Arakawa T. Optimization of lyophilization conditions for recombinant human interleukin-2 by dried-state conformational analysis using Fourier-transform infrared spectroscopy. Pharmaceutical Research, 12 : 1250-1259. 1995.
22. Ressing ME, Jiskoot W, Talsma H, van Ingen CW, Beuvery EC and Crommelin DJ. The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12). Pharmaceutical Research, 9 : 266-270. 1992.
23. Sarker SA, Casswall TH, Juneja LR, Hoq E, Hossain I, Fuchs GJ and Hammarstrom L. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. Journal of Pediatric Gastroenterology and Nutrition, 32 : 19-25. 2001.
24. Suzuki H, Nomura S, Masaoka T, Goshima H, Kamata N, Kodama Y, Ishii H, Kitajima M, Nomoto K and Hibi T. Effect of dietary anti-Helicobacter pylori-urease immunoglobulin Y on Helicobacter pylori infection. Alimentary Pharmacology & Theraputics, 20 (Suppl 1) : 185-192. 2004.
25. Timasheff SN. Control of protein stability and reactions by weakly interacting cosolvents : the simplicity of the complicated. Advances in Protein Chemistry, 51 : 355-432. 1998.
26. Warr GW, Magor KE and Higgins DA. IgY : clues to the origins of modern antibodies. Immunology Today, 16 : 392-398. 1995.
27. Winward DB and Brophy MT. Acute renal failure after administration of intravenous immunoglobulin : review of the literature and case report. Pharmacotherapy, 15 : 765-772. 1995.
28. Zhang MZ, Wen J, Arakawa T and Prestrelski SJ. A new strategy for enhancing the stability of lyophilized protein : the effect of the reconstitution medium on keratinocyte growth factor. Pharmaceutical Research, 12 : 1447-1452. 1995.
29. Zhang MZ, Pikal K, Nguyen T, Arakawa T and Prestrelski SJ. The effect of the reconstitution medium on aggregation of lyophilized recombinant interleukin-2 and ribonuclease A. Pharmaceutical Research, 13 : 643-646. 1996.